InvesTrust Takes Position in The Procter & Gamble Company (NYSE:PG)

InvesTrust bought a new stake in shares of The Procter & Gamble Company (NYSE:PG) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 40,746 shares of the company’s stock, valued at approximately $6,821,000. Procter & Gamble accounts for approximately 1.9% of InvesTrust’s investment portfolio, making the stock its 21st biggest holding.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble in the second quarter worth $28,000. Fairway Wealth LLC acquired a new stake in Procter & Gamble in the 2nd quarter worth $29,000. RPg Family Wealth Advisory LLC acquired a new position in shares of Procter & Gamble during the third quarter valued at about $33,000. Quest Partners LLC bought a new stake in shares of Procter & Gamble in the second quarter valued at about $36,000. Finally, Fairfield Financial Advisors LTD bought a new position in Procter & Gamble during the second quarter valued at about $44,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now directly owns 11,566 shares in the company, valued at approximately $1,954,538.34. The trade was a 52.53 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the sale, the chief executive officer now owns 13,783 shares of the company’s stock, valued at $2,343,110. This trade represents a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 75,439 shares of company stock worth $13,317,460. Insiders own 0.18% of the company’s stock.

Procter & Gamble Trading Up 0.4 %

Shares of PG stock traded up $0.62 on Wednesday, reaching $161.92. 2,196,216 shares of the stock were exchanged, compared to its average volume of 5,983,573. The stock has a 50 day moving average price of $169.92 and a 200 day moving average price of $169.75. The stock has a market cap of $381.33 billion, a PE ratio of 27.92, a P/E/G ratio of 3.70 and a beta of 0.45. The Procter & Gamble Company has a one year low of $146.28 and a one year high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55.

Procter & Gamble (NYSE:PG) last released its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s revenue was down .6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.83 EPS. Equities research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on PG shares. JPMorgan Chase & Co. lifted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Evercore ISI boosted their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Morgan Stanley lifted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Wells Fargo & Company cut their price target on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research note on Tuesday. Finally, Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research note on Monday, September 30th. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $179.75.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.